GBA Presents: THE GREEN MARKET

Well I did my annual look through my boxes and now I'm just depressed. All these photos when my boy was young, cards from various birthdays and valentines days when my wife really liked and appreciated me. What the hell has happened.
 
Van talk to me--

SelectQuote options imply 17.9% move in share price post-earnings 14:04 SLQT Pre-earnings options volume in SelectQuote is 1.5x normal with puts leading calls 7:4. Implied volatility suggests the market is anticipating a move near 17.9%, or $1.19, after results are released. Median move over the past eight quarters is 14.6%.
 
Velodyne Lidar (NASDAQ:VLDR) surged 87% in after hours trading after Amazon received a warrant to purchase up to 39.6M of the company's shares.

The vesting of the warrant shares is based on discretionary payments made by Amazon pursuant to existing commercial agreements between Velodyne and Amazon, according to an 8-K filing. The warrant may be any time before Feb. 4, 2030 at an exercise price of $4.18 per share, which was determined based on the 30-day volume-weighted average price for the common stock as of Feb 3.
 
stonedinvestor said:
Nice spot.... Tech is a confusing minefield right now. Chip shortage is very bad still & virus still reeking havoc with certain Far east factories.

I'm looking at SMOD today.

testing its 10-week moving averageon a pullback.<---------

Silicon Motion reports its fourth-quarter results on Thursday morning, with an estimated EPS of $1.76 and revenue of $262 million. The company will hope to end the fiscal year off in style: 2021 full-year earnings per share estimated at $6.01, over an 85% increase from a year prior. Analysts expect growth to continue into next year, with 2022 EPS projected at $7.11.

AND VERTEX<----- I think you are already in. I recommended this name to you once before.

Vertex Reports Wednesday after close.
Vertex Pharmaceuticals(VRTX) is another drug manufacturer displaying impressive profit growth. The maker of cystic fibrosis drugs is set to report earnings on Wednesday after the market close.

EPS is estimated at $3.26, with a revenue of $2 billion. Investors should expect beats on both these numbers, as with AmerisourceBergen. Vertex analysts have consistently underestimated numbers. The company has beat both EPS and revenue estimates for 12 straight quarters.

Vertex Pharmaceuticals has had an impressive growth rate, with three-year EPS and sales growth rates at 56% and 29%, respectively. Vertex is forming a long base with a handle and has a 224.50 buy point,

TODAY IDEAS))))))

SMOD-$ 83.50

VRTX- $227
More...




Lets talk about VRTX after we bought it made an amazing run to $250 something and pulled back a bit I did not sell and I don't think Van did either!
 
stonedinvestor said:
Van talk to me--

SelectQuote options imply 17.9% move in share price post-earnings 14:04 SLQT Pre-earnings options volume in SelectQuote is 1.5x normal with puts leading calls 7:4. Implied volatility suggests the market is anticipating a move near 17.9%, or $1.19, after results are released. Median move over the past eight quarters is 14.6%.
More...
Put a fork in it stoney.
It's done.
Down 40% on a bad report.
 
You must log in or register to reply here.
Back
Top